ANIX - Anixa Biosciences Inc

QQQ $ 479.30 $ 2.47 (0.52 %)

DIA $ 386.46 $ -0.42 (-0.11 %)

SPY $ 542.65 $ 0.33 (0.06 %)

TLT $ 94.67 $ 0.79 (0.84 %)

GLD $ 215.76 $ 2.76 (1.3 %)

Previous Close

$ 2.61

Open

$ 2.68

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 2.63 - $ 2.69

52 Week Range

$ 2.21 - $ 5.13

Volume

42,830

Average Volume

Market Cap

83.54M

Beta (5Y Monthly)

$ 0.69

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	06-04-2024	04-30-2024	10-Q
2	03-12-2024	01-31-2024	10-Q
3	01-16-2024	10-31-2023	10-K
4	09-06-2023	07-31-2023	10-Q
5	06-14-2023	04-30-2023	10-Q
6	03-17-2023	01-31-2023	10-Q
7	01-04-2023	10-31-2022	10-K
8	09-09-2022	07-31-2022	10-Q
9	06-10-2022	04-30-2022	10-Q
10	03-11-2022	01-31-2022	10-Q
11	01-04-2022	10-31-2021	10-K
12	09-01-2021	07-31-2021	10-Q
13	06-10-2021	04-30-2021	10-Q
14	03-11-2021	01-31-2021	10-Q
15	01-07-2021	10-31-2020	10-K
16	09-08-2020	07-31-2020	10-Q
17	06-09-2020	04-30-2020	10-Q
18	03-09-2020	01-31-2020	10-Q
19	01-09-2020	10-31-2019	10-K
20	09-06-2019	07-31-2019	10-Q
21	06-12-2019	04-30-2019	10-Q
22	03-13-2019	01-31-2019	10-Q
23	01-11-2019	10-31-2018	10-K
24	09-07-2018	07-31-2018	10-Q
25	06-11-2018	04-30-2018	10-Q
26	03-09-2018	12-01-2017	10-Q
27	01-09-2018	10-31-2017	10-K
28	09-08-2017	07-31-2017	10-Q
29	05-26-2017	04-30-2017	10-Q
30	03-16-2017	01-31-2017	10-Q
31	12-07-2016	10-31-2016	10-K
32	08-19-2016	07-31-2016	10-Q
33	05-20-2016	04-30-2016	10-Q
34	02-19-2016	01-31-2016	10-Q
35	12-23-2015	10-31-2015	10-K
36	08-18-2015	07-31-2015	10-Q
37	05-22-2015	04-30-2015	10-Q
38	03-09-2015	01-31-2015	10-Q
39	01-29-2015	10-31-2014	10-K
40	09-15-2014	07-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Maintains Buy on Anixa...
06/10/2024 10:42:52

HC Wainwright & Co. analyst Yi Chen maintains Anixa Biosciences (NASDAQ:ANIX) with a Buy and lowers the price target fro...

Anixa Biosciences Begins Treatment Of Fift...
05/21/2024 11:33:51

Anixa Biosciences Partners With Cleveland ...
05/08/2024 12:27:48

Anixa Biosciences 13D Filing Shows Preside...
05/03/2024 17:34:09

- SEC Filing

HC Wainwright & Co. Reiterates Buy on Anix...
03/21/2024 10:33:41

HC Wainwright & Co. analyst Yi Chen reiterates Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $12 price target.

Recap: Anixa Biosciences Q1 Earnings
03/12/2024 21:45:06

HC Wainwright & Co. Reiterates Buy on Anix...
02/13/2024 17:28:22

HC Wainwright & Co. analyst Yi Chen reiterates Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $12 price target.

Anixa Biosciences Initiates Dosing in Seco...
02/12/2024 12:33:39

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ:ANIX), a clinical-stage biotechnology company focus...

Anixa Biosciences Announces Japanese Paten...
01/23/2024 13:06:35

Broad coverage extended to Japan and related regionsSAN JOSE, Calif., Jan. 23, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. (&#...

anixa-biosciences-reveals-updated-data-from-breast-cancer-vaccine-trial-says-exceeded-expectations

Anixa Biosciences Reveals Updated Data Fro...
12/07/2023 14:58:22

Anixa Biosciences Inc (NASDAQ: ANIX) announced new and updated results from the Phase 1 trial of its breast cancer vaccine.

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
12/07/2023 13:07:04

HC Wainwright & Co. Reiterates Buy on Anix...
12/07/2023 11:28:07

HC Wainwright & Co. analyst Yi Chen reiterates Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $12 price target.

Anixa Biosciences And Cleveland Clinic Pre...
12/06/2023 23:01:42

Anixa Biosciences To Host Conference Call ...
12/06/2023 21:19:17

– Data to be released at approximately 6:00 p.m. ET, following presentation at 2023 SABCS –– Conference call to commence at 6:3...

Anixa Biosciences Announces European Paten...
11/27/2023 13:44:12

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ:ANIX), a biotechnology company focused on the treatm...

Anixa Biosciences Completes Treatment Of F...
10/13/2023 12:35:23

- With no dose-limiting toxicities observed, treatment of second dose cohort to beginSAN JOSE, Calif., Oct. 13, 2023 /PRNewswir...

Stocks That Hit 52-Week Lows On Tuesday
10/03/2023 18:37:58

On Tuesday, 647 companies set new 52-week lows.

Anixa Biosciences Announces Issuance Of Ad...
10/03/2023 12:34:03

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ:ANIX), a biotechnology company focused on the treatm...

HC Wainwright & Co. Reiterates Buy on Anix...
09/18/2023 16:19:01

HC Wainwright & Co. analyst Yi Chen reiterates Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $12 price target.

HC Wainwright & Co. Reiterates Buy on Anix...
08/29/2023 10:12:35

HC Wainwright & Co. analyst Yi Chen reiterates Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $12 price target.

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)

07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)

07/01/2024 Equinix, Inc. (EQIX)

07/02/2024 Intel Corporation (INTC)

07/05/2024 AXT, Inc. (AXTI)

07/05/2024 Altimmune, Inc. (ALT)

07/09/2024 Li Auto Inc. (LI)

07/12/2024 Inari Medical, Inc. (NARI)

07/12/2024 Sprout Social, Inc. (SPT)

07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)

ANIXAnixa Biosciences Inc

Nasdaq anixa.com

$ 2.63 $ -0.11 (-4.04 %)

Friday, 14-Jun-2024 15:59:28 EDT